• Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization …
• Policy statement: Use of pharmacometrics in drug submissions and clinical trial applications
• Guidance Document - Quality (Chemistry and Manufacturing) Guidance: Clinical Trial Applications (CTAs) …
• Notice - Publication of information about certain Clinical Trial Applications authorized by …
• Clinical Trial Applications (CTAs) - requirements